A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan

Study Overview
=================
Brief Summary
-----------------
This study is conducted in Asia. The aim of this observational study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in Asia.

Official Title
-----------------
DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Asia.

Conditions
-----------------
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Intervention / Treatment
-----------------
* Other: No treatment given


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diabetic patients registered in the particular centre for more than 12 months Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit Patients willing to sign informed consent form Exclusion Criteria: Repetition of any patient as patients should not be included twice for any reason Unwilling to participate or unable to comply with protocol requirements
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| A<br> | Other: No treatment given<br>* Subject will only fill out a questionaire when entering the observational study.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mean age of onset of type 1 and type 2 diabetes mellitus |  | at baseline visit/study start | 
| Mean duration of treatment of type 2 diabetes mellitus. |  | at baseline visit/study start | 
| Percentage of patients on Insulin and Oral Anti-Diabtetics Drug (OADs) therapy, respectively |  | at baseline visit/study start | 
| Mean duration of diabetes in type 1 and type 2 patients respectively |  | at baseline visit/study start | 
| Mean FPG (fasting plasma glucose),PPG (post prandial glucose) and HbA1c of diabetic patients. |  | at baseline visit/study start | 
| Percentage of diabetic patients with HbA1c target below 7.0% and below 6.5%, respectively |  | at baseline visit/study start | 
| Percentage of diabetic patients having dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications, respectively |  | at baseline visit/study start | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patients' perception will be analysed through Patient questionnaire measuring: Psychological well-being, Quality of life and Patients' compliant to treatment |  | at baseline visit/study start | 
| Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about: HbA1c test and its goal, anti-diabetic treatment, barriers towards optimum diabetes control |  | at baseline visit/study start | 
| Duration of diabetes associated with highest number of diabetic complications |  | at baseline visit/study start | 
| Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy) |  | at baseline visit/study start |